1. Home
  2. PASG vs PRSO Comparison

PASG vs PRSO Comparison

Compare PASG & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

N/A

Current Price

$3.38

Market Cap

14.6M

Sector

Health Care

ML Signal

N/A

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.37

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASG
PRSO
Founded
2017
2008
Country
United States
United States
Employees
27
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
13.4M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
PASG
PRSO
Price
$3.38
$0.37
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $15.50
N/A
AVG Volume (30 Days)
15.5K
★ 11.3M
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 81.23
EPS
N/A
★ N/A
Revenue
N/A
★ $14,573,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$191.73
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 5.99
52 Week Low
$3.29
$0.36
52 Week High
$20.00
$2.10

Technical Indicators

Market Signals
Indicator
PASG
PRSO
Relative Strength Index (RSI) 34.64 42.56
Support Level $3.29 $0.36
Resistance Level $4.92 $0.52
Average True Range (ATR) 0.36 0.05
MACD -0.03 0.00
Stochastic Oscillator 1.93 6.18

Price Performance

Historical Comparison
PASG
PRSO

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.

Share on Social Networks: